Search

CDC and Abt collaborated to evaluate immunogenicity of influenza vaccines among healthcare personnel in open-label trial.

This report from Abt provides qualitative context to New York City’s poverty data, describing challenges the city’s citizens face.

Be it outbreak, epidemic, or pandemic—human or zoonotic—the goal is to get reliable information on infectious diseases, quickly. Abt experts Laura Edwards and Sung-Woo Cho discuss strategies for harnessing machine learning and data visualization to provide actionable information—at scale—that can help stem a health crisis.

How do we defeat tuberculosis? With sustainable solutions. With support from the private sector. With data.

In this month’s episode, Abt experts Jill Berkowitz and Sung-Woo Cho discuss how machine learning can amplify our work combatting malaria—25 million people protected to date—by applying what we’ve learned to other infectious diseases.

Abt is a sponsor and exhibitor at the American Public Health Association (APHA) 2024 Annual Meeting & Expo in October 2024.

Abt Global is sponsoring the Global Health Security Conference on June 18-21 in Sydney, Australia. 

This Future of Health Systems series webinar focuses on the evolving health systems landscape and how MEL strategies are indispensable for improving performance.